Dispersyn Gerrit 4
4 · Phio Pharmaceuticals Corp. · Filed Feb 16, 2022
Insider Transaction Report
Form 4
Dispersyn Gerrit
Chief Development Officer
Transactions
- Award
Common stock, $0.0001 par value
2022-02-15+126,000→ 221,281 total
Footnotes (2)
- [F1]Represents shares underlying a restricted stock unit, which shares will vest in three equal annual installments.
- [F2]Includes shares of common stock underlying unvested restricted stock units.